Detalhe da pesquisa
1.
Pathological significance of abnormal recepteur d'origine nantais and programmed death ligand 1 expression in colorectal cancer.
World J Gastrointest Oncol
; 12(11): 1216-1236, 2020 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33250957
2.
RON and MET Co-overexpression Are Significant Pathological Characteristics of Poor Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Triple-Negative Breast Cancer.
Cancer Res Treat
; 52(3): 973-986, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32324988
3.
Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Pancreatic Cancer.
Front Oncol
; 9: 1377, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31867280